Since transdermal therapeutic systems (TTS) for scopolamine and nitroglycerin were first introduced on the U.S. market, more than twenty drugs have been clinically available as skin patches for treating a variety of diseases. These patches are applied on the surface of intact skin, and the therapeutic efficacy as well as the undesired side effect is influenced by the environmental temperature.
a 75 mm-thick PET film, and cut to a desired size to obtain Patch A, where the drug constituents were completely dissolved in the adhesive. Further, SIS, Liquid paraffin, ARKON P-100, and Macrogol 6000 were weighed in mixing vessel, and treated similarly as above to obtain a solution. After cooling the solution to 100-125°C, Felbinac was added alone to the solution. This mixture was stirred for 20 min to afford a solution. The solution was similarly treated as above to obtain Patch B, where the drug was completely dissolved in the adhesive.
In Vitro Skin Permeation Study
In vitro side-by-side skin permeation system, a hydrodynamically well-calibrated permeation system, was used in this investigation. Abdominal skin of hairless mouse (Hr-/Kud strain, 7 weeks old, Kyudo Co., Ltd., Saga, Japan) was freshly excised.
Experiment 1 Patch A cut into pieces (3.14 cm 2 ) was applied to the stratum corneum (SC) side of the skin. The dermal side of the skin was mounted on the horizontal sideby-side diffusion cell (effective area: 0.64 cm 2 ) as shown in Fig. 1 . The donor compartment of the diffusion cell, which was thermo-regulated using a water jacket, was filled with 4.8 ml distilled water. The donor temperature was fixed to 2, 25, 37, and 47°C, respectively. The receptor compartment was kept at 37°C and filled with 4.8 ml phosphate buffer solution (pH 7.4) during the experiment. At predetermined time intervals, 0.1 ml aliquots of sample solution were withdrawn from the receptor compartment and the deficiencies were replaced with fresh phosphate buffer solution. Drug concentration in the receptor solution was determined by using an HPLC system consisting of LC-20AD (Shimadzu Corp., Kyoto, Japan) and Mightysil RP-18GP (4.6 mmϫ150 mm, Kanto Chemical Co., Inc., Tokyo, Japan) column. UV detector was operated at 222 nm for Loxoprofen and 254 nm for Felbinac, Ketoprofen, Flurbiprofen, respectively. An equivolume mixture of acetonitrile and potassium phosphate buffer (0.05 M, pH 4.0) was delivered as the mobile phase at a flow rate of 1 ml/min at 40°C. Experiment 2 The Patch B cut into pieces (3.14 cm 2 ) was applied to the SC side of the skin. The dermal side of the skin was mounted on the horizontal side-by-side diffusion cell. The other conditions were similarly operated as Experiment 1 except the donor temperature at 2 or 42°C.
Experiment 3 The Patch B cut into pieces (3.14 cm 2 ) was applied directly to the horizontal side-by-side diffusion cell without the skin. The other conditions were similarly operated as Experiment 2.
Experiment 4 The Patch B cut into pieces (3.14 cm 2 ) was applied to the SC side of the skin. The dermal side of the skin was mounted on the horizontal side-by-side diffusion cell. The donor compartment of the diffusion cell, which was thermo-regulated using a water jacket, was filled with 4.8 ml distilled water. The temperature was varied sequentially at every predetermined time. The receptor compartment was kept at 37°C and filled with 4.8 ml phosphate buffer solution (pH 7.4) during the experiment. The other conditions were similarly operated as Experiment 1. Vol. 33, No. 12 Fig. 2 the permeation of the drugs from Patch A increases with increasing the donor temperature. Transdermal kinetic parameters for the model drugs thus determined are summarized in Table 3 . In this study, we assumed the skin as a single-layer which consists of the SC, because major obstacle to drug penetration resides in SC. Further, we employed the skin surface temperature to be the average of donor and receptor temperatures, because the temperature measured with thermo sensor indicated that the skin surface had approximately the mean of donor and receptor temperatures. The steady state rate of permeation of the drugs (flux) was given by dQ/dt, where Q is the cumulative amount of drug permeated, t is the time. The diffusion coefficient in the skin (D) was determined from the thickness of the SC (h) and the lag time The receptor compartment temperature was maintained constant at 37°C.
RESULTS

In Vitro Skin Permeation Experiments As shown in
verse of skin surface temperature. D remained almost constant, indicating that the diffusion coefficient in the SC hardly increased by the rise of environmental temperature. On the other hand, the drug solubility to the SC increased with increasing skin surface temperature. In the present study, we carried out the in vitro experiments to demonstrate the effect of environmental temperature on the penetration of the some lipophilic drugs having similar molecular weight (MW: 212-254). As a result, the flux increased with increasing the donor temperature. The drug diffusion in the skin remained almost constant, while the drug solubility to the SC increased with increasing skin surface temperature. The result of this study indicates that the mechanism of the enhancement effect of temperature differs from that of chemical enhancers. Next, we experimented using Patch B, of which Felbinac concentration in adhesive is the same as the over-the-counter (OTC) patches in Japan. Figure 6 shows that the permeation of Felbinac from Patch B increases with increasing the donor temperature similar to Patch A. Figure 7 shows that the release of Felbinac from Patch B increases with increasing the donor temperature. This result indicates that the drug diffusion in the adhesive layer increased with the adhesive temperature. The diffusion coefficient in the adhesive layer (D p ) was determined from the following relationship 5) and summarized in Table 4 . M t /M ϱ ϭ4(D p t/pl 2 ) 1/2 , where M t is the mass of drug released at time t, M ϱ is the total mass of drug initially in the patch and released at time t ϱ , and l is the thickness of the adhesive layer. For conventional transdermal patches, diffusion across the skin is usually a rate-limiting step, therefore, diffusion in the patch is insignificant in the overall penetration process. In the present study, D was smaller appreciably than D p at each donor temperature, and the penetration of the drug hardly increased with increasing the adhesive temperature. Figure 8 shows the dynamic response of the donor temperature on the penetration of Felbinac from Patch B. The donor temperature was originally maintained at 42°C for the 0-4 h and then decreased to 2°C at 4 h and again maintained for the 4-7 h and then finally returned to 42°C at 7 h. After allowing little lag time, the penetration of the drug quickly varied with responding to the environmental temperature. 
Simulation of Pharmacokinetics in Human
The skin permeation of drug and its plasma concentration in human were simulated by SKIN-CAD ® . 6) As reported by many researchers, 7, 8) the diffusion coefficient and the skin surface concentration from hairless mouse skin can be used for human skin except that the thickness of the skin should be modified for the human skin. The thickness of human SC is presumed to be 10 to 20 mm. Figure 9 shows the simulated skin permeation of Ketoprofen. Ketoprofen is selected as a model compound, because the pharmacokinetic parameters for mathematical simulation are commonly available.
9) The skin surface temperature was initially 35°C, and lowered to 20°C at 8 h later, and finally returned to 35°C at 16 h after the beginning. D and C s at 35°C were evaluated from the Arrhenius plots (Figs. 4, 5 (Fig. 4) . When the skin surface temperature was varied from 35 to 20°C, the penetration rate decreased allowing lag time of 1-4 h. On the other hand, when the temperature was varied to 35°C, the rate increased immediately. Figure 10 shows the simulated blood concentration profile of Ketoprofen after the application of Patch A with 70 cm 2 under the same condition of Fig. 9 . The elimination rate constant (k e ) and volume of distribution (V d ) were obtained from the literature 9) : k e ϭ0.675/h, V d ϭ7.7 l. When the skin surface temperature was varied from 35 to 20°C, the blood concentration dropped allowing lag time of 0-3 h. On the other hand, when the temperature was varied to 35°C, the blood concentration enhanced allowing lag time of 0-3 h again. Lag time of change in blood concentration was influenced on the condition with SC. This result indicates that the skin penetration of drug into thin skin site is thermosensitive. In this in silico experiment, we have used Ketoprofen, but the response may be faster in drugs with shorter half lives.
CONCLUSION
In the present study, we have demonstrated the effect of environmental temperature on the penetration behaviors of the some lipophilic drugs from matrix-type transdermal patches using some NSAIDs as the models. In vitro permeation experiments followed by in silico pharmacokinetic treatments revealed that the diffusion coefficient of the NSAIDs in the skin were almost constant, while the drug solubility to the SC proportionally increased with environmental temperature. In addition, the skin surface concentration was correlated with skin surface temperature. From these findings we finally inferred that the environmental temperature affected only the behavior of drug on the SC surface, and as the result, the diffusion coefficient of drug on the skin were constant. In the isothermal in which donor and receptor compartment are kept at the same temperature, the diffusion coefficients is correlated with the donor and receptor temperatures. The result derived from anisothermal system shows that the rate of drug diffusion is not markedly influenced by temperature. We surmised that the rise in temperature increased drug solubility to the bilayer lipids in SC and consequently the penetration of the drugs increased. Considering that we live under variety of environment temperature such the case as taking bath and walking outside in a cold day, we must pay attention to the temperature whenever applying us transdermal patches. For instance, during bath, the skin surface temperature will heat up to about 42°C, and when outside in a cold day, the skin surface temperature may cool down to about 20°C or much lower. The simulation data from the in vitro permeation experiment clearly show that blood level of drug promptly changes with variation the environment temperature. In addition, cutaneous vasodilation and vasoconstriction in response to heating and cooling of skin cause change in local skin blood flow. The skin surface temperature was initially 35°C, and lowered to 20°C at 8 h later, and finally returned to 35°C at 16 h after the beginning.
